High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia. 1988

A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias

Related Publications

A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
September 1982, British medical journal (Clinical research ed.),
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
December 1991, American journal of hematology,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
May 1993, Arthritis and rheumatism,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
December 2007, Pediatric blood & cancer,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
July 1999, The Journal of the Association of Physicians of India,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
September 2002, Annals of internal medicine,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
January 2002, Lupus,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
May 2010, Arthritis and rheumatism,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
July 1984, Archives of internal medicine,
A Winkler, and R W Jackson, and D S Kay, and E Mitchell, and S Carmignani, and G C Sharp
April 1992, The Indian journal of medical research,
Copied contents to your clipboard!